Results 281 to 290 of about 861,864 (406)

Figure S1 from Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells

open access: gold
Vinod Ganju   +7 more
openalex   +1 more source

Streptozotocin induced hyperglycemia in the axolotl

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background Diabetes is a group of diseases characterized by loss of β cell mass and/or function, resulting in hyperglycemia. With no established curative treatment, this has initiated research in β cell regeneration. Current animal models have either limited regenerative capacity (mice) or small size and evolutionary distance from humans ...
Pernille Lajer Sørensen   +2 more
wiley   +1 more source

Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individuals. [PDF]

open access: yesGastro Hep Adv
Diwan EA   +9 more
europepmc   +1 more source

Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial.

open access: yesEndoscopy, 2011
E. Zolotarevsky   +14 more
semanticscholar   +1 more source

Zur Technik der klinischen Pankreastransplantation: Ist die Okklusionsmethode sinnvoll? [PDF]

open access: yes, 1983
Büll, U.   +4 more
core   +1 more source

Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.

open access: yesInternal medicine, 2011
Kei Ito   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy